MedPath

A Comparative Study of yogik procedure and herbal compound in the management of skin disease.

Phase 3
Completed
Conditions
Health Condition 1: L400- Psoriasis vulgaris
Registration Number
CTRI/2022/07/043831
Lead Sponsor
ational Institute of Ayurveda Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

Subjects with Classical Signs and symptoms of Mandal Kushtha.

Exclusion Criteria

Pregnant, Menstruating women and Lactating mothers.

Subjects suffering from other severe systemic or skin disorders.

Subjects taking any other medicine for Mandal Kushtha .

Especially for Kunjal- abdominal hernia, recent abdominal surgeries, glaucoma, HT, abdominal tumor.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in PASI Scores <br/ ><br>Timepoint: 8 weeks <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
Changes in classical signs and symptoms- Kandu, Daha, Vaivarnya. <br/ ><br>Improvement in Varnyaprasadan. <br/ ><br>Timepoint: 8 weeks
© Copyright 2025. All Rights Reserved by MedPath